Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Tryptamine Therapeutics ( (AU:TYP) ).
Tryptamine Therapeutics Limited has announced an update related to the proposed issue of securities, adjusting the date of the Extraordinary General Meeting (EGM) and the subsequent proposed issue date. This update reflects a significant procedural adjustment, which may affect the company’s financial planning and stakeholder expectations.
More about Tryptamine Therapeutics
YTD Price Performance: 7.89%
Average Trading Volume: 1,842,510
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$52.33M
Learn more about TYP stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue